<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR74">
 <label>74</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Smith</surname>
    <given-names>Melody</given-names>
   </name>
   <name>
    <surname>García-Martínez</surname>
    <given-names>Elena</given-names>
   </name>
   <name>
    <surname>Pitter</surname>
    <given-names>Michael R.</given-names>
   </name>
   <name>
    <surname>Fucikova</surname>
    <given-names>Jitka</given-names>
   </name>
   <name>
    <surname>Spisek</surname>
    <given-names>Radek</given-names>
   </name>
   <name>
    <surname>Zitvogel</surname>
    <given-names>Laurence</given-names>
   </name>
   <name>
    <surname>Kroemer</surname>
    <given-names>Guido</given-names>
   </name>
   <name>
    <surname>Galluzzi</surname>
    <given-names>Lorenzo</given-names>
   </name>
  </person-group>
  <article-title>Trial Watch: Toll-like receptor agonists in cancer immunotherapy</article-title>
  <source>OncoImmunology</source>
  <year>2018</year>
  <volume>7</volume>
  <issue>12</issue>
  <fpage>e1526250</fpage>
  <pub-id pub-id-type="doi">10.1080/2162402X.2018.1526250</pub-id>
  <?supplied-pmid 30524908?>
  <pub-id pub-id-type="pmid">30524908</pub-id>
 </element-citation>
</ref>
